Human Coronavirus-229E Hijacks Key Host-Cell RNA-Processing Complexes for Replication.

Human Coronavirus-229E Hijacks Key Host-Cell RNA-Processing Complexes for Replication.

Publication date: Sep 12, 2025

The recent rise in zoonotic coronavirus outbreaks underscores the urgency to understand virus-host interactions to develop potent antiviral therapeutics. Systems biology approaches, particularly proteomics, have been invaluable in providing a global overview of such interactions. However, these conventional approaches rely on measuring protein abundance changes that do not capture all molecular changes associated with altered regulatory pathways. In this study, we employed a high-throughput structural proteomics approach called limited proteolysis-based mass spectrometry (LiP-MS) to capture protein conformational changes, which we demonstrate are better proxies for functional alterations. We applied this tool to profile the molecular landscape of different human lung cells following human coronavirus-229E (HCoV-229E) infection. We found that HCoV-229E uses a multipronged approach to hijack key RNA-processing pathways and assemblies as part of a host-shutoff strategy to achieve effective replication. We confirm our results with structural data derived from changes in the assemblies after infection. We go on to show that modulation of two of these assemblies, the Nop56-associated pre-rRNA complex and the spliceosome C-complex, can attenuate HCoV-229E replication, indicating that we have identified viable host-cell therapeutic targets with potential to provide broad efficacy against coronavirus infection.

Concepts Keywords
Coronavirus coronavirus
Hijacks host shutoff
Invaluable host−pathogen interactions
Molecular limited proteolysis
Zoonotic structural proteomics

Semantics

Type Source Name
disease IDO host
disease IDO cell
disease IDO replication
disease IDO protein
drug DRUGBANK Tropicamide
disease MESH infection
pathway KEGG Spliceosome
disease MESH coronavirus infection

Original Article

(Visited 11 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *